Eire, thank you for posting this, it is an amazing interview.
This panel discussion involving people connected to the company directly and also indirectly leaves me with no doubt that DurAVR is the future of TAVR.....
Whether we (Anteris) control its destiny going forward or whether it is another entity (Edwards, Medtronic, J&J) I am highly confident that within the next decade basically ALL TAVR procedures will be done with DurAVR.
A lot of discussion on here about, why doesn't the market catch on, when will the market catch on, etc..... Impossible to know or predict. BUT when it does catch on, and it could happen for any one of a multitude of reasons this company will re-rate hard and fast. Fortunately I am set in my position so will just continue to wait happily and patiently until this company's true worth reveals itself.... what other option is there!?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)